Table 4 Baseline participant characteristics
Characteristics | Total (N = 11) n (%) or m ± SD |
|---|---|
Biological Sex | |
Male | 3 (27.3%) |
Female | 8 (72.7%) |
Age | 71.91 ± 9.87 |
Height (in) | 66.81 ± 4.35 |
Weight (lbs) | 187.73 ± 59.49 |
Ethnicity | |
White, not of Hispanic origin | 7 (63.6%) |
Black/African American | 4 (36.4%) |
Cancer stage | |
I | 10 (90.9%) |
II | 1 (9.1%) |
Treatment characteristics | |
Surgery | 5 (45.5%) |
Surgery & chemotherapy | 3 (27.3%) |
Surgery & radiotherapy | 1 (9.1%) |
Radiotherapy | 2 (18.2%) |
Immunotherapy | 0 (0%) |
Time since diagnosis (months) | 62 ± 51 |
Sarcopenic | 2 (18.2%) |
Comorbidities (self-report) | |
Cardiovascular disease | 1 (9.1%) |
Respiratory conditions | 7 (63.6%) |
Diabetes | 2 (18.2%) |
Osteoporosis/osteoarthritis | 2 (18.2%) |